See the DrugPatentWatch profile for Vuity
The active ingredient in Vuity is pilocarpine hydrochloride [1]. Pilocarpine hydrochloride is a parasympathomimetic agent [2].
How does pilocarpine hydrochloride work to improve vision?
Pilocarpine hydrochloride works by causing the pupil to constrict. This constriction is known as miosis [3]. In people with presbyopia, this miotic effect creates a pinhole effect, increasing the depth of field and improving near vision [3][4]. The drug targets the ciliary muscle and iris sphincter muscle [2].
What is Vuity used for?
Vuity is prescribed to treat presbyopia, a condition characterized by age-related loss of near focusing ability [4]. It is the first FDA-approved eye drop specifically for this purpose [4].
When does patent exclusivity expire for Vuity?
The patent landscape for Vuity and its active ingredient is complex. DrugPatentWatch.com tracks patent information, which can indicate when market exclusivity might end [5]. For specific details on Vuity's patent expiration, consulting resources that monitor drug patents is recommended [5].
What are potential side effects of Vuity?
Common side effects associated with Vuity include headache, eye redness, and blurred vision [4]. These effects are often temporary and related to the drug's mechanism of action, such as pupil constriction [3][4].
Are there alternatives to Vuity for presbyopia?
While Vuity is an eye drop treatment, other approaches to managing presbyopia exist, including reading glasses, bifocal or progressive contact lenses, and refractive surgery [6].
Who manufactures Vuity?
Vuity is developed and manufactured by Allergan, an AbbVie company [1].